MA50763A - Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires - Google Patents

Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires

Info

Publication number
MA50763A
MA50763A MA050763A MA50763A MA50763A MA 50763 A MA50763 A MA 50763A MA 050763 A MA050763 A MA 050763A MA 50763 A MA50763 A MA 50763A MA 50763 A MA50763 A MA 50763A
Authority
MA
Morocco
Prior art keywords
disorders
amino acid
treatment methods
acid compositions
muscle diseases
Prior art date
Application number
MA050763A
Other languages
English (en)
Inventor
Raffi Afeyan
William Comb
Michael Hamill
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA50763A publication Critical patent/MA50763A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA050763A 2016-12-19 2017-12-19 Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires MA50763A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662436073P 2016-12-19 2016-12-19
US201762443205P 2017-01-06 2017-01-06
US201762491776P 2017-04-28 2017-04-28
US201762545358P 2017-08-14 2017-08-14
US201762576321P 2017-10-24 2017-10-24

Publications (1)

Publication Number Publication Date
MA50763A true MA50763A (fr) 2019-10-23

Family

ID=61025047

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050763A MA50763A (fr) 2016-12-19 2017-12-19 Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires

Country Status (21)

Country Link
US (3) US20180207119A1 (fr)
EP (1) EP3554493A1 (fr)
JP (1) JP2020502183A (fr)
KR (1) KR20190099243A (fr)
CN (1) CN110267655A (fr)
AU (1) AU2017379825A1 (fr)
BR (1) BR112019012476A2 (fr)
CA (1) CA3046558A1 (fr)
CL (1) CL2019001685A1 (fr)
CO (1) CO2019006292A2 (fr)
CU (1) CU20190057A7 (fr)
EC (1) ECSP19043725A (fr)
IL (1) IL267210A (fr)
JO (1) JOP20190147A1 (fr)
MA (1) MA50763A (fr)
MX (1) MX2019007352A (fr)
PE (1) PE20191206A1 (fr)
PH (1) PH12019501339A1 (fr)
TW (1) TWI780096B (fr)
WO (1) WO2018118957A1 (fr)
ZA (1) ZA201903581B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
SG11202001131TA (en) * 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of neuronal injury
EP3668499A1 (fr) 2017-08-14 2020-06-24 Axcella Health Inc. Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
CA3099762A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Procedes de fabrication de compositions d'acides amines
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
EP3810123A1 (fr) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
US20210393593A1 (en) * 2018-09-27 2021-12-23 Societe Des Produits Nestle S.A. Use of histidine, glycine and other amino acids for preventing insulin resistance and/or diabetes
KR102338447B1 (ko) * 2019-09-24 2021-12-14 마이오텍사이언스 주식회사 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물
KR102456270B1 (ko) * 2019-09-24 2022-10-19 마이오텍사이언스 주식회사 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물
CN110801007A (zh) * 2019-12-17 2020-02-18 苟春虎 老年肌少症营养肽
US20230089723A1 (en) * 2020-03-06 2023-03-23 Axcella Health Inc. Amino acid compositions and methods for muscle and myotube modulation
CN113288890B (zh) * 2021-06-21 2022-02-22 南方医科大学南方医院 N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用
WO2024026307A1 (fr) 2022-07-25 2024-02-01 Axcella Health Inc. Biomarqueur pour covid longue et fatigue
WO2024030909A1 (fr) 2022-08-01 2024-02-08 Axcella Health Inc. Biomarqueurs de réponse au traitement d'une composition d'acides aminés dans covid long

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022927A3 (cs) * 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20060002913A1 (en) * 2004-06-22 2006-01-05 Gehlsen Kurt R Use of histamine and related compounds to treat disorders affecting muscle function
JP5545424B2 (ja) * 2005-03-29 2014-07-09 味の素株式会社 高齢者の骨格筋量減少を防止又は改善するためのアミノ酸含有組成物
JP2007023921A (ja) * 2005-07-19 2007-02-01 Toyota Motor Corp 内燃機関の制御装置
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
CN100518815C (zh) * 2007-02-15 2009-07-29 北京苏里曼医药科技有限公司 一种氨基酸组合物
MX2014001996A (es) * 2011-08-19 2014-08-29 Musclepharm Corp Composiciones y metodos para usarse en promover masa corporal magra.
JP2017501113A (ja) * 2013-10-23 2017-01-12 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ アミノ酸によるｍＴＯＲＣ１の調節およびその使用

Also Published As

Publication number Publication date
PH12019501339A1 (en) 2019-09-30
MX2019007352A (es) 2019-09-05
US20180169046A1 (en) 2018-06-21
CL2019001685A1 (es) 2019-08-30
JOP20190147A1 (ar) 2019-06-18
BR112019012476A2 (pt) 2020-04-14
US20180169047A1 (en) 2018-06-21
PE20191206A1 (es) 2019-09-10
JP2020502183A (ja) 2020-01-23
US20180207119A1 (en) 2018-07-26
CN110267655A (zh) 2019-09-20
IL267210A (en) 2019-08-29
WO2018118957A1 (fr) 2018-06-28
CA3046558A1 (fr) 2018-06-28
AU2017379825A1 (en) 2019-06-13
ZA201903581B (en) 2020-12-23
CO2019006292A2 (es) 2019-06-28
KR20190099243A (ko) 2019-08-26
CU20190057A7 (es) 2020-02-04
EP3554493A1 (fr) 2019-10-23
TWI780096B (zh) 2022-10-11
TW201827068A (zh) 2018-08-01
ECSP19043725A (es) 2019-07-31

Similar Documents

Publication Publication Date Title
MA50763A (fr) Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires
MA51451A (fr) Compositions d'acides aminés et méthodes de traitement de maladies hépatiques
MA51200A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies
PH12018500087A1 (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
HK1246712A1 (zh) 神經刺激治療疾病及病症
MA45798A (fr) Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers
MA44126A (fr) Méthodes de traitement de maladies et troubles pulmonaires
CO2020001702A2 (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática
EA201992607A1 (ru) Твердые формы берберина урсодезоксихолата, их композиции и способы
IL272336A (en) Amino acid compounds for the treatment of nerve damage
WO2015197193A3 (fr) Nouvelle utilisation de molécules inhibitrices de jnk pour le traitement de diverses maladies
CU20160151A7 (es) 2-AMIN0-6-METI L-4,4a, 5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
SG11202004971YA (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
EA201892265A1 (ru) Способы лечения офтальмологических заболеваний
EA201492102A1 (ru) Антагонисты lingo-2 для лечения заболеваний, в которых участвуют двигательные нейроны
MA50905A (fr) Composés et compositions pharmaceutiques de ceux-ci destinés à être utilisés dans le traitement de maladies fibrotiques
MX2018005628A (es) Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo.
IL264070A (en) Methods and preparations for the treatment of disorders and diseases involving rdh12
MA43800A (fr) Octréotide par voie orale pour le traitement de maladies
MA53741A (fr) Procédés de traitement de troubles myéloprolifératifs
MA47595A (fr) Méthodes de traitement d'affections neurodégénératives
MA53636A (fr) Agent de traitement de troubles dermatologiques
MA53745A (fr) Procédés de traitement de troubles myéloprolifératifs
SG11202010034WA (en) TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRß ANTIBODY
FR2990107B1 (fr) Composition a base de glycine betaine et applications pour la prevention et/ou le traitement de maladies de plantes